The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The relationship between common EGFR, b-raf, k-ras mutations, and prognosis in advanced-stage NSCLC with response to the treatment.
M. Dogan
No relevant relationships to disclose
A. Demirkazik
No relevant relationships to disclose
A. Tukun
No relevant relationships to disclose
H. Akbulut
No relevant relationships to disclose
S. Dizbay Sak
No relevant relationships to disclose
K. Ceyhan
No relevant relationships to disclose
B. Yalcin
No relevant relationships to disclose
F. Icli
No relevant relationships to disclose